UltraSound for Accurate Decisions in Chest PhysioTherapy (US-ADEPT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02881814

Recruitment Status : Recruiting

First Posted : August 29, 2016

Last Update Posted : February 5, 2020

See Contacts and Locations

Sponsor:

Collaborators:

Hôpital Forcilles

Centre Hospitalier Universitaire Dijon

St Vincent's Hospital, Sydney

Information provided by (Responsible Party):

Groupe Hospitalier Paris Saint Joseph

Study Description

Brief Summary:

Introduction: Physiotherapist usually uses a clinical examination, including auscultation, an analysis of blood gasses and chest imaging to determine the indication for chest physiotherapy, to choose the treatment protocol and evaluate the efficacy of the management. Lung ultrasound (LUS) presents greater accuracy than chest X-ray in the diagnosis of lung deficiencies interesting the physiotherapist. So, it could allow the physiotherapist to determine the indication for chest physiotherapy and thus avoid unnecessary or inappropriate treatments. No study has evaluated the impact of LUS on clinical decisions in chest physiotherapy in ICU patients.

Objective: To evaluate the impact of using the results of lung and diaphragm US on clinical decisions in chest physiotherapy in hypoxemic patients hospitalized in ICU.

Method: The physiotherapist carries out a clinical examination and analyses the complementary tests (chest X-ray, chest CT-scan and blood gasses if available). Following the examination, he will put forward one or several hypotheses concerning the respiratory deficiency and will confirm or not the indication for chest physiotherapy. If respiratory physiotherapy is indicated, the physiotherapist will specify the protocol.

A lung and diaphragm US will be done following the evaluation of the clinical physiotherapist, and will make it possible to answer the question: are the results of the lung and diaphragm US compatible with the hypotheses put forward? The LUS report will be given to the clinical physiotherapist. He will specify the respiratory physiotherapy protocol according to the results of the US-scan.

The modification of the clinical decision will be assessed with the Net Reclassification Index (NRI).

Expected results: We expect that decisions for chest physiotherapy will be modified by LUS. The expected benefit for patients is therefore that they will be given a chest physiotherapy protocol that is better suited to the type of respiratory deficiency they are suffering from.

Condition or disease	Intervention/treatment	Phase
Critical Illness Respiratory Disease	Diagnostic Test: Lung and diaphragm ultrasound	Not Applicable

Show detailed description

Detailed Description:

Research hypothesis The lung and diaphragm ultrasound findings provided to the physiotherapist will modify his/her clinical decision-making in regards to chest physiotherapy treatment in the critical care patient.

Objectives Principal objective The principal objective of this study is to evaluate the impact of using the results of lung and diaphragm US on clinical decisions by physiotherapists regarding chest physiotherapy in patients hospitalized in an ICU.

Secondary objectives

Determine the accuracy of physiotherapist diagnosis of lung pathology using routine clinical assessment versus LUS findings;
Determine the frequency of change in chest physiotherapy treatment with the addition of LUS results to clinical assessment;
Determine the frequency of change in medical treatment (determined by intensivist) following the addition of LUS results to clinical assessment findings.
Evaluate the diagnostic accuracy of LUS in predicting duration of mechanical ventilation and mortality.

Methodology:

Type of study This is a multi-centre prospective (patients enrolled on admission) interventional study evaluating a routine assessment/treatment. The study intends to assess the impact of lung and diaphragm ultrasound on the usual physiotherapist's clinical decision-making process. Each included patient will be clinically assessed by a clinical physiotherapist, and then will have a lung and diaphragm ultrasound by another physiotherapist/operator blinded to the clinical assessment findings. The lung and diaphragm ultrasound findings will then be presented to both the intensivist and clinical physiotherapist to evaluate the impact on the independent clinical decision-making by both the intensivist and physiotherapist.

Data collections

The following data will be collected:

Demographic: age, sex, BMI, smoking, alcohol consumption, history of cirrhosis, diabetes or a chronic respiratory disease, heart failure;
Reason for hospitalization, medical diagnosis if different;
Treatments: hypnotics, opiates, steroids and anti-hypertensives, oxygen therapy, mechanical ventilation, NIV, tracheotomy;
Duration of mechanical ventilation
Duration of ICU stay
Vital signs: RR, HR, PA, SpO2, RASS, Glasgow;
Clinical hypotheses of the clinical physiotherapist;
LUS findings;
Choice of chest physiotherapy protocol (before and after ultrasonography).

Nature of the routine care to be evaluated Procedure 1: Decision-making process in chest physiotherapy The clinical physiotherapist is the physiotherapist who manages patients in the CCU.

As soon as chest physiotherapy is prescribed, the physiotherapist carries out a clinical examination and analyses the complementary tests (chest X-ray, chest CT-scan and blood gasses if available). He/she also consults the patient's medical record to find out the reason for admission to the CCU and the medical diagnosis if the critical care physician has made one. Following the examination, he/she will put forward one or several hypotheses concerning the respiratory deficiency (and not the disease - medical diagnosis) and will confirm or not the indication for chest physiotherapy. If respiratory physiotherapy is indicated, the physiotherapist will specify the protocol.

A lung and diaphragm US will be done (see below) following the evaluation of the clinical physiotherapist, and will make it possible to answer the question: are the results of the lung and diaphragm US compatible with the hypotheses put forward? The LUS report will be given to the clinical physiotherapist. It will specify the respiratory physiotherapy protocol according to the results of the US-scan.

Procedure 2: lung and diaphragm US The LUS will be performed by the physiotherapist/operator, who will be blinded to the clinical evaluation of the clinical physiotherapist and the patient's status. The operator will not take part in the management of the patients concerned. The semiology of lung and diaphragm US is described. The following syndromes will be searched for: normal profile, alveolar-interstitial syndrome, pulmonary consolidation, pleural effusion, pneumothorax and diaphragm dysfunction. The physiotherapist/operator will write a detailed LUS-scan report, which will be given to the clinical physiotherapist. It will include the LUS diagnosis and describe the signs observed in the different regions of the chest. The clinical physiotherapist is trained to interpret LUS reports.

In case of mechanically ventilated patient, LUS scan will be performed immediately following intubation. Additionnal LUS scans will be performed 72h after intubation and Immediately prior to or following extubation.

Number of patients to recruit and duration of participation for each patient Given the high prevalence of hypoxemia in ICUs, the systematic respiratory assessment in these patients by the physiotherapist and our relatively non-restrictive inclusion criteria, we believe we can recruit more than 300 patients per year.

Study Design

Layout table for study information

Study Type :	Interventional (Clinical Trial)
Estimated Enrollment :	150 participants
Intervention Model:	Single Group Assignment
Masking:	None (Open Label)
Primary Purpose:	Diagnostic
Official Title:	Evaluation of the Impact of Lung and Diaphragm Ultrasound Findings on Clinical Decisions for Chest Physiotherapy in Patients Hospitalized in Intensive Care Units
Actual Study Start Date :	November 14, 2017
Estimated Primary Completion Date :	March 31, 2020
Estimated Study Completion Date :	September 14, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ultrasound

U.S. FDA Resources

Arms and Interventions

Arm	Intervention/treatment
Experimental: Lung ultrasound and clinical decision	Diagnostic Test: Lung and diaphragm ultrasound The ultrasound physiotherapist/operator performs a lung and diaphragm ultrasound. He is blinded to the patient's status and clinical physiotherapist examination. He/she is not involved in patient management or patient clinical decision-making. The ultrasound findings are recorded in the LUS report. The LUS report is reported to the clinical physiotherapist and to the intensivist. The ultrasound diagnosis(es) is recorded.

Arm

Intervention/treatment

Experimental: Lung ultrasound and clinical decision

Diagnostic Test: Lung and diaphragm ultrasound

The ultrasound physiotherapist/operator performs a lung and diaphragm ultrasound. He is blinded to the patient's status and clinical physiotherapist examination. He/she is not involved in patient management or patient clinical decision-making. The ultrasound findings are recorded in the LUS report. The LUS report is reported to the clinical physiotherapist and to the intensivist. The ultrasound diagnosis(es) is recorded.

Outcome Measures

Primary Outcome Measures :

Net Reclassification Index (NRI) [ Time Frame: Hour 1 ]
Agreement (yes/no) between the lung and diaphragm US diagnosis and the clinical diagnosis and modification (yes/no) of the chest physiotherapy protocol

Secondary Outcome Measures :

Prediction of duration of mechanical ventilation [ Time Frame: Final study visit ]
Number of days with mechanical ventialtion
Prediction of mortality [ Time Frame: Final study visit ]
Vital status at the end of ICU hospitalization

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information

Ages Eligible for Study:	18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion criteria

Hypoxemia(SpO2/FiO2< 315 (15))(indication for chest physiotherapy)(cf. annexe 1);
Medical prescription for chest physiotherapy;
First session of chest physiotherapy;
Chest X-ray<12h available;
Physiotherapist/operator qualified in LUS available;
Patient's consent.

Exclusion criteria

Presence of a contra-indication for chest physiotherapy;
Absence of hypoxemia;
Absence of a prescription for chest physiotherapy;
Absence of a chest X-ray < 12h from the time of physiotherapy assessment;
Physiotherapist/operator qualified in LUS not available;
Lung and diaphragm US not possible (surgical emphysema, dressing, scarring, drains etc.);
Refusal of the patient or a relative to participate in the study;
Patients to be discharged on the day of the study;
Patients in palliative care;
Withdrawal/limitations of medical care with impending death.

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02881814

Contacts

Layout table for location contacts

Contact: Aymeric Le Neindre, PhD	+331 60 64 61 30	aymeric.leneindre@gmail.com
Contact: Hélène Beaussier, PharmD, PhD

Locations

Layout table for location information

Australia
St Vincent's Hospital	Recruiting
Sydney, Australia, NSW2010
Contact: George Ntoumenopoulos, PhD
Sub-Investigator: Louise Hansell, PhD
France
Groupe Hospitalier Paris Saint Joseph	Recruiting
Paris, Ile-de-France, France, 75014
Contact: Hélène Beaussier, PharmD, PhD +33 1 44 12 70 38 hbeaussier@hpsj.fr
Sub-Investigator: François Philippart, MD, PhD
CHU de Dijon	Recruiting
Dijon, France, 21000
Contact: Belaid Bouhemad, MD, PhD
Hôpital Forcilles	Recruiting
Férolles-Attilly, France, 77150
Contact: Aymeric Le Neindre, PhD +336 60 64 61 30 aymeric.leneindre@gmail.com

Sponsors and Collaborators

Groupe Hospitalier Paris Saint Joseph

Hôpital Forcilles

Centre Hospitalier Universitaire Dijon

St Vincent's Hospital, Sydney

Investigators

Layout table for investigator information

Study Director:	Belaid Bouhemad, MD, PhD	Centre Hospitalier Universitaire Dijon
Principal Investigator:	Aymeric Le Neindre, PhD	Hôpital Forcilles
Principal Investigator:	George Ntoumenopoulos, PhD	St. Vincent's Hospital-Manhattan

More Information

Publications of Results:

Xirouchaki N, Georgopoulos D. Impact of lung ultrasound on clinical decision making in critically ill patients: response to O'Connor et al. Intensive Care Med. 2014 Jul;40(7):1063. doi: 10.1007/s00134-014-3316-6. Epub 2014 May 6.

Le Neindre A, Mongodi S, Philippart F, Bouhemad B. Thoracic ultrasound: Potential new tool for physiotherapists in respiratory management. A narrative review. J Crit Care. 2016 Feb;31(1):101-9. doi: 10.1016/j.jcrc.2015.10.014. Epub 2015 Oct 26. Review.

Leech M, Bissett B, Kot M, Ntoumenopoulos G. Lung ultrasound for critical care physiotherapists: a narrative review. Physiother Res Int. 2015 Jun;20(2):69-76. doi: 10.1002/pri.1607. Epub 2014 Dec 29. Review.

Layout table for additonal information

Responsible Party:	Groupe Hospitalier Paris Saint Joseph
ClinicalTrials.gov Identifier:	NCT02881814
Other Study ID Numbers:	US-ADEPT
First Posted:	August 29, 2016 Key Record Dates
Last Update Posted:	February 5, 2020
Last Verified:	February 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD:	Undecided

Layout table for additional information

Studies a U.S. FDA-regulated Drug Product:	No
Studies a U.S. FDA-regulated Device Product:	No

Keywords provided by Groupe Hospitalier Paris Saint Joseph:


Lung ultrasound Chest physiotherapy Decision-making process Diagnostic

Additional relevant MeSH terms:

Layout table for MeSH terms

Respiration Disorders Critical Illness Respiratory Tract Diseases Disease Attributes Pathologic Processes

To Top